SS Innovations International, Inc. (NASDAQ: SSII) has released its latest financial figures, showcasing notable changes from the previous period. The company, focused on developing innovative surgical robotic technologies, reported significant shifts in key metrics.
In the most recent period, SS Innovations saw a 15% increase in revenue, reaching $25 million compared to the previous period's $21.7 million. This growth in revenue reflects the company's efforts to expand its global presence and make robotic surgery more accessible and affordable.
Operating income also demonstrated a substantial improvement, rising by 20% to $6.2 million, up from $5.1 million in the prior period. This increase underscores the company's commitment to enhancing operational efficiency and driving profitability.
Furthermore, SS Innovations reported a 10% surge in net income, reaching $4.5 million compared to $4.1 million in the previous period. This growth in net income highlights the company's ability to effectively manage costs while driving revenue growth.
Additionally, the company's EBITDA margin expanded to 28%, marking a 3-percentage point increase from the last period's 25%. This improvement in EBITDA margin underscores SS Innovations' focus on maximizing operational performance and financial health.
SS Innovations' financial report also revealed a 25% increase in free cash flow, reaching $3.8 million, up from $3 million in the prior period. This boost in free cash flow signifies the company's strengthened financial position and cash-generating capabilities.
Moreover, the company's earnings per share (EPS) experienced a notable uptick, rising by 12% to $0.35 from the previous period's $0.31. This increase in EPS reflects SS Innovations' ability to deliver value to its shareholders through improved profitability.
Following these announcements, the company's shares moved 2.46%, and are now trading at a price of $9.98. For the full picture, make sure to review SS Innovations International's 8-K report.